Company Revenue

The company grew in the mid-single-digits in the fourth quarter of 2024 and set records for its enabling technology sales...

The company's orthopedic sales grew in the mid-single-digits for calendar year 2024 as its enabling technology disrupts market dynamics....

The company grew 3.8% in 2024 driven by better operational performance and strategic efforts to enter higher-growth markets....

The company's orthopedic sales grew below-market at 2% in 2024 as it worked through significant supply chain challenges....

The company's orthopedic sales grew in the high single digits in 2024, driven by new products and healthy procedure demand....

The company's orthopedic business grew in the low-single-digits in 2024 as it faced restructuring and competitive headwinds....

The company grew in the high-teens in the third quarter of 2024, as its wide-ranging portfolio insulated it from market...

The company grew in the mid-single digits, driven by its broad product portfolio and increasing U.S. market penetration....

The company grew in the mid-single digits on a pro forma basis in the third quarter of 2024 as it...

The company grew 63% on a reported basis in the third quarter of 2024 as it anniversaried its merger with...